FEED (ENvue Medical) Beginning Cash Position: $4.25 Mil (As of Mar. 2026)


FEED ENvue Medical Inc FEED
37 GF Score
Price $0.52
GF Value $5.13
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is ENvue Medical Beginning Cash Position?

ENvue Medical FEED -8.77% 37 Beginning Cash Position is $4.25 Mil as of Mar. 2026. GuruFocus rates FEED with a GF Score™ of 37/100 and a GF Value™ of $5.13 (Possible Value Trap). The stock has 4 warning signs investors should review.

ENvue Medical's Beginning Cash Position for the quarter that ended in Mar. 2026 was $4.25 Mil.

ENvue Medical's quarterly Beginning Cash Position increased from Sep. 2025 ($4.06 Mil) to Dec. 2025 ($6.98 Mil) but then declined from Dec. 2025 ($6.98 Mil) to Mar. 2026 ($4.25 Mil).

ENvue Medical's annual Beginning Cash Position increased from Dec. 2023 ($2.71 Mil) to Dec. 2024 ($3.28 Mil) but then declined from Dec. 2024 ($3.28 Mil) to Dec. 2025 ($0.75 Mil).

ENvue Medical Beginning Cash Position Related Terms

ENvue Medical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for ENvue Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENvue Medical Beginning Cash Position Chart

ENvue Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.53 7.74 2.71 3.28 0.75

ENvue Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.60 4.06 6.98 4.25
FEED
37GF Score
ENvue Medical Inc FEED
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENvue Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $4.25 Mil mean?
ENvue Medical (FEED) has a Beginning Cash Position of $4.25 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on ENvue Medical and its competitors.
Is ENvue Medical's Beginning Cash Position too high?
ENvue Medical's current Beginning Cash Position is $4.25 Mil. Overall, ENvue Medical has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ENvue Medical's Beginning Cash Position compare to BTCY and LUDG?
ENvue Medical's Beginning Cash Position of $4.25 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on ENvue Medical and its competitors. ENvue Medical's current Beginning Cash Position is $4.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENvue Medical stock overvalued right now?
Based on GuruFocus' analysis, ENvue Medical (FEED) is currently considered Possible Value Trap. The stock's GF Value™ is $5.13, compared to a current price of $0.52 — trading 89.8% below its estimated fair value. The current Beginning Cash Position is $4.25 Mil. ENvue Medical's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For ENvue Medical (FEED), the current Beginning Cash Position is $4.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ENvue Medical (FEED) Overvalued in 2026?

Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued. The current stock price of $0.52 is trading 89.8% below its estimated GF Value™ of $5.13. GuruFocus considers ENvue Medical to be Possible Value Trap.

Key valuation signals for FEED:

  • Beginning Cash Position: $4.25 Mil
  • GF Value™: $5.13 vs. price of $0.52 (89.8% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FEED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ENvue Medical Business Description

Address 969 Pruitt Avenue, Tyler, TX, USA, 77569
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
37GF Score

Get the complete analysis for FEED

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price
$5.13
GF Value